Document is current

Any future updates will be listed below

The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

Crossref DOI link: https://doi.org/10.1186/2047-9158-3-11

Published Online: 2014-06-02

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark